Results 221 to 230 of about 61,456 (351)

A Comparison of Budesonide and Prednisone for the Treatment of Active Pediatric Crohn Disease

open access: bronze, 2003
Arie Levine   +9 more
openalex   +1 more source

Impact of biologic induction dose and concomitant drugs on anti‐drug antibody formation in a pediatric IBD cohort with high Hispanic representation

open access: yesJPGN Reports, EarlyView.
Abstract Objectives The use of biologic therapy is increasing in pediatric patients with inflammatory bowel disease (IBD). However, efficacy may be compromised by increased drug clearance and anti‐drug antibodies (ADAs). Historically, concomitant immunomodulator therapy (CIT) has been used to prevent ADA formation. Pediatric studies evaluating CIT have
Kenneth Grant   +3 more
wiley   +1 more source

Reliability of CT Enterography for Describing Fibrostenosing Crohn Disease. [PDF]

open access: yesRadiology
Rieder F   +20 more
europepmc   +1 more source

CARD15 Genotype and Phenotype Analysis in 55 Pediatric Patients With Crohn Disease From Saxony, Germany

open access: bronze, 2003
Liping Sun   +6 more
openalex   +1 more source

Drug‐induced liver injury associated with selective androgen receptor modulators in an adolescent patient

open access: yesJPGN Reports, EarlyView.
ABSTRACT Selective androgenic receptor modulators (SARMs) have similar properties to anabolic steroids but bind to androgen receptors in a tissue‐specific manner. Studies have investigated the benefits of SARMs in promoting bone and muscle growth while limiting the adverse effects of androgenic stimulation of other organs.
David J. Katibian   +3 more
wiley   +1 more source

Posttraining survey of recent pediatric gastroenterology fellowship graduates

open access: yesJPGN Reports, EarlyView.
Abstract Objectives The North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) Training Committee conducted a survey of recent fellowship graduates to assess their confidence in procedure performance, disease management, practice habits, and satisfaction with mentorship.
Christopher J. Moran   +12 more
wiley   +1 more source

First-line anti-TNF agents, ustekinumab and vedolizumab perform similarly in Crohn' disease, but not in ulcerative colitis. [PDF]

open access: yesEur J Gastroenterol Hepatol
Supovec E   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy